IP Library › Assignment 062083/0252
Patent Assignment
Reel/Frame 062083/0252

Change of Name

Recorded: 2022-12-07 Pages: 2
Assignor
UCB BIOPHARMA SPRL
Executed: 2019-12-02
Assignee
UCB BIOPHARMA SRL
ALLEE DE LA RECHERCHE 60, BRUSSELS, 1070, BELGIUM
Covered Property (1)
Gremlin-1 Inhibitor for the Treatment of a Bone Fracture or Bone Defect
Application: 18/062,608 →
Publication: US 2023/0174635
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 7, 2022
From: DAVIES, GARETH CHARLES GLYNDWR; ROBERTS, SCOTT JOHN
To: CELLTECH R&D LIMITED
Reel/Frame 062011/0418 →
Assignment of Assignor's Interest Dec 7, 2022
From: CELLTECH R&D LIMITED
To: UCB BIOPHARMA SPRL
Reel/Frame 062011/0737 →